A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 100.75
GOOG 577.36
MSFT 46.36
BAC 17.05
FB 79.04

Recently Added

SHW 218.99
LOCO 35.91
SYNA 73.20
SQNS 1.98
SIMO 26.94

Gaining Speed

CVLT 50.40
SYNA 73.20
DTLK 10.63
LOCO 35.91
SHW 218.99

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More

Get Alerted When News Hits On This Stock - FREE!